Global Endometriosis Market 2012-2016

Global Endometriosis Market 2012-2016

Category : Healthcare

------------ Or -------------

TechNavio's analysts forecast the Global Endometriosis market to grow at a CAGR of 5.86 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increased number of incidence rates of endometriosis. The market has also been witnessing an increased number of awareness programs. However, poor safety and efficacy of existing drugs could pose a challenge to the growth of this market. 

TechNavio's report, the Global Endometriosis Market 2012–2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Endometriosis market in the Americas, EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space include AbbVie Inc., AstraZeneca Plc., Bayer Inc., and Pfizer Inc.

The other vendors mentioned in the report are AEterna Zentaris Inc., KV Pharmaceuticals Company, Neurocrine Biosciences Inc., and Repros Therapeutics Inc. 

Key questions answered in this report: 
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

4.1. Market Research Process

4.2. Research Design

4.3. Research Methodology

5. Scope of the Report

5.1. Market Overview

5.2. Product Offerings

5.3. Product Profiles

6. Market Landscape

6.1. Global Endometriosis market 2012–2016 

6.1.1. Market Size and Forecast 

7. Five Force Analysis

8. Geographical Segmentation

9. Rate of Incidence and Prevalence

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis

17.1. AbbVie Inc.

17.1.1. Business Overview

17.1.2. Key Information

17.1.3. SWOT Analysis

17.2. Pfizer Inc.

17.2.1. Business Overview

17.2.2. Key Information

17.2.3. SWOT Analysis

17.3. AstraZeneca PLC.

17.3.1. Business Overview

17.3.2. Key Information

17.3.3. SWOT Analysis

17.4. Bayer Inc.

17.4.1. Business Overview

17.4.2. Key Information

17.4.3. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Endometriosis Market 2012–2016 (US$ billion)

Exhibit 3: Therapies Used in the Treatment of Endometriosis

Exhibit 4: Therapies Used in the Treatment of Endometriosis (in percentage)

Exhibit 5: Global Endometriosis Market by Geographical Segmentation 2012

Enquiry Before Buy